Características clínicas y pronóstico de pacientes con cáncer de mama HER2 positivo avanzado, en la era antes y después de terapias anti-HER2

por SÁNCHEZ,CESAR, DOMÍNGUEZ,FRANCISCO, GALINDO,HÉCTOR, CAMUS,MAURICIO, ODDÓ,DAVID, VILLARROEL,ALEJANDRA, RAZMILIC,DRAVNA, NAVARRO,MARÍA ELENA, PÉREZ-SEPÚLVEDA,ALEJANDRA, MEDINA,LIDIA, LÓPEZ,VALESKA, ACEVEDO,FRANCISCO
Publicado 2018

Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer

por Salkeni MA, Rizvi W, Hein K, Higa GM
Publicado 2021

Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review

por Linehan AS, Fitzpatrick OM, Morris PG
Publicado 2021

Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature

por Belal Firwana, Bassel Atassi, Rim Hasan, Nour Hasan, Ammar Sukari
Publicado 2012

Reversible cardiotoxicity in a 54-year-old woman treated with trastuzumab

por Martins,Sandro José, Modesto Dos Santos,Vitorino, Thommen Teles,Ludmila, Alves Leite,Viviane
Publicado 2012

Impact of HER2 receptor status on axillary nodal burden in patients with non-luminal A invasive ductal breast carcinoma

por Kustic,Domagoj, Lovasic,Franjo, Belac-Lovasic,Ingrid, Avirovic,Manuela, Ruzic,Alen, Petretic-Majnaric,Silvana
Publicado 2019

Assessment of Myocardial Work in Cancer Therapy-Related Cardiac Dysfunction and Analysis of CTRCD Prediction by Echocardiography

por Jingyuan Guan, Wuyun Bao, Yao Xu, Wei Yang, Mengmeng Li, Mingjun Xu, Yu Zhang, Mei Zhang
Publicado 2021

From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer

por Rodallec A, Sicard G, Giacometti S, Carré M, Pourroy B, Bouquet F, Savina A, Lacarelle B, Ciccolini J, Fanciullino R
Publicado 2018

Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo

por Duan D, Wang A, Ni L, Zhang L, Yan X, Jiang Y, Mu H, Wu Z, Sun K, Li Y
Publicado 2018

Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity

por Esteban Cruz, Vicki Sifniotis, Zeynep Sumer-Bayraktar, Mouhamad Reslan, Lorna Wilkinson-White, Stuart Cordwell, Veysel Kayser
Publicado 2021

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer

por Rodallec A, Brunel JM, Giacometti S, Maccario H, Correard F, Mas E, Orneto C, Savina A, Bouquet F, Lacarelle B, Ciccolini J, Fanciullino R
Publicado 2018

Nano-Encapsulation of Coenzyme Q10 in Secondary and Tertiary Nano-Emulsions for Enhanced Cardioprotection and Hepatoprotection in Human Cardiomyocytes and Hepatocytes During Exposu...

por Quagliariello V, Vecchione R, De Capua A, Lagreca E, Iaffaioli RV, Botti G, Netti PA, Maurea N
Publicado 2020

Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data

por Jagosky M, Tan AR
Publicado 2021

Combination of Near-Infrared Photoimmunotherapy Using Trastuzumab and Small Protein Mimetic for HER2-Positive Breast Cancer

por Haruka Yamaguchi, Jotaro On, Takao Morita, Takamasa Suzuki, Yasuo Okada, Junya Ono, Andreas Evdokiou
Publicado 2021

A Importância do Monitoramento e da Identificação Precoce de Cardiotoxicidade do Tratamento com Trastuzumabe no Câncer de Mama: Relato de Caso

por Patricia Marques Soares Valente, Walter Claudino Pires de Souza, Eduardo Pinho Braga, Thamires Ferreira Neves, Thamires Lopes da Silva, Wolney de Andrade Martins, Selma Rodrigues de Castilho
Publicado 2019

Cardiotoxicidade nas Terapias Neoadjuvante e Adjuvante do Câncer de Mama

por Livia Christina de Oliveira Pina, Flavia Axelband, Maria Fernanda Barbosa, Mario Jorge Sobreira da Silva
Publicado 2019

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam

por Phung HT, Thi Nguyen H, Nguyen TV, Nguyen TV, Dinh LAT, Nguyen CV
Publicado 2020

Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells

por Rodríguez-Serrano F, Mut-Salud N, Cruz-Bustos T, Gomez-Samblas M, Carrasco E, Garrido JM, López-Jaramillo FJ, Santoyo-Gonzalez F, Osuna A
Publicado 2016

Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy

por Michał Żuk, Weronika Gawęda, Agnieszka Majkowska-Pilip, Magdalena Osial, Marcin Wolski, Aleksander Bilewicz, Paweł Krysiński
Publicado 2021

Data provision of PIK3CA gene diversity and recombinant plasmids preparation for control DNA in developing the trastuzumab predictive response diagnostic kit

por DESRIANI DESRIANI, BUGI RATNO BUDIARTO, WIRSMA ARIF HARAHAP, M. ALI WARISMAN, AUDREY VANIA CLARISSA OMPUSUNGGU, DINA ATHARIAH, FARIDA MIRNAWATI, IDA YUSSRIYANI, FUAD ALAHWANI, AHMAD RIZQI KURNIAWAN
Publicado 2016